Back to News
Market Impact: 0.15
CONMED Reaches Analyst Target Price
Source: Nasdaq
Analyst InsightsMarket Technicals & Flows
CONMED Corp (CNMD) shares recently traded at $47.23, above the average analyst 12-month target price of $47.00. The article notes analysts could respond by downgrading the stock on valuation or raising their targets; the supplied text gives no further details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
CNMD0.00
More News
- What Wall Street billionaires are saying about Democrats' midterm sweep
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Oil and data centre stocks sink after US midterms
- ‘Seismic’ blue wave triggers the sinking of oil prices, energy stocks, and the chances of power permitting reform
- Oil Price Forecast: WTI and Brent Plunge After US Midterm Elections
- Nifty Bounces Back to Beat All of Asia on Foreign Flows, Earnings
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- The Great Divergence: North American Banking at the Crossroads of Monetary Policy and Agentic AI (Q4 2025 Bank Earnings)
- How to Extract KPIs From Earnings Transcripts With AI